Ascend Wellness Holdings, Inc. (OTC:AAWH - Free Report) - Equities research analysts at Ventum Cap Mkts issued their Q1 2025 earnings per share (EPS) estimates for shares of Ascend Wellness in a research report issued on Thursday, March 13th. Ventum Cap Mkts analyst A. Semple expects that the company will earn ($0.07) per share for the quarter. The consensus estimate for Ascend Wellness' current full-year earnings is ($0.40) per share. Ventum Cap Mkts also issued estimates for Ascend Wellness' Q2 2025 earnings at ($0.06) EPS, Q3 2025 earnings at ($0.06) EPS, Q4 2025 earnings at ($0.05) EPS, FY2025 earnings at ($0.25) EPS and FY2026 earnings at ($0.20) EPS.
Ascend Wellness Price Performance
AAWH traded up $0.01 during trading on Monday, hitting $0.36. The company's stock had a trading volume of 112,425 shares, compared to its average volume of 125,264. The company has a current ratio of 1.47, a quick ratio of 0.80 and a debt-to-equity ratio of 2.61. Ascend Wellness has a twelve month low of $0.27 and a twelve month high of $1.55. The business's fifty day simple moving average is $0.37 and its 200 day simple moving average is $0.56. The firm has a market capitalization of $77.19 million, a price-to-earnings ratio of -0.88 and a beta of 1.27.
About Ascend Wellness
(
Get Free Report)
Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.
Featured Articles
Before you consider Ascend Wellness, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ascend Wellness wasn't on the list.
While Ascend Wellness currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
